Connection
Jennifer Diamond to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications Jennifer Diamond has written about Randomized Controlled Trials as Topic.
|
|
Connection Strength |
|
 |
|
 |
|
0.115 |
|
|
|
-
Weiss J, Glode A, Messersmith WA, Diamond J. Sacituzumab govitecan: breakthrough targeted therapy for triple-negative breast cancer. Expert Rev Anticancer Ther. 2019 08; 19(8):673-679.
Score: 0.115